These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34477105)
1. Concerted conformational dynamics and water movements in the ghrelin G protein-coupled receptor. Louet M; Casiraghi M; Damian M; Costa MG; Renault P; Gomes AA; Batista PR; M'Kadmi C; Mary S; Cantel S; Denoyelle S; Ben Haj Salah K; Perahia D; Bisch PM; Fehrentz JA; Catoire LJ; Floquet N; Banères JL Elife; 2021 Sep; 10():. PubMed ID: 34477105 [TBL] [Abstract][Full Text] [Related]
2. Sodium is a negative allosteric regulator of the ghrelin receptor. Ferré G; Gomes AAS; Louet M; Damian M; Bisch PM; Saurel O; Floquet N; Milon A; Banères JL Cell Rep; 2023 Apr; 42(4):112320. PubMed ID: 37027306 [TBL] [Abstract][Full Text] [Related]
3. Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor. Mary S; Damian M; Louet M; Floquet N; Fehrentz JA; Marie J; Martinez J; Banères JL Proc Natl Acad Sci U S A; 2012 May; 109(21):8304-9. PubMed ID: 22573814 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the Dynamics of the Human Growth Hormone Secretagogue Receptor Reveals Insights into the Energy Landscape of the Molecule. Smith AA; Pacull EM; Stecher S; Hildebrand PW; Vogel A; Huster D Angew Chem Int Ed Engl; 2023 Aug; 62(35):e202302003. PubMed ID: 37205715 [TBL] [Abstract][Full Text] [Related]
5. THE INTRIGUING LIGAND-DEPENDENT AND LIGAND-INDEPENDENT ACTIONS OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR ON REWARD-RELATED BEHAVIORS. Cornejo MP; Mustafá ER; Barrile F; Cassano D; De Francesco PN; Raingo J; Perello M Neurosci Biobehav Rev; 2021 Jan; 120():401-416. PubMed ID: 33157147 [TBL] [Abstract][Full Text] [Related]
6. Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors. Rediger A; Piechowski CL; Yi CX; Tarnow P; Strotmann R; Grüters A; Krude H; Schöneberg T; Tschöp MH; Kleinau G; Biebermann H J Biol Chem; 2011 Nov; 286(45):39623-31. PubMed ID: 21940628 [TBL] [Abstract][Full Text] [Related]
7. Enhanced responsiveness of Ghsr Q343X rats to ghrelin results in enhanced adiposity without increased appetite. Chebani Y; Marion C; Zizzari P; Chettab K; Pastor M; Korostelev M; Geny D; Epelbaum J; Tolle V; Morisset-Lopez S; Pantel J Sci Signal; 2016 Apr; 9(424):ra39. PubMed ID: 27095593 [TBL] [Abstract][Full Text] [Related]
9. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists. Ramirez VT; van Oeffelen WEPA; Torres-Fuentes C; Chruścicka B; Druelle C; Golubeva AV; van de Wouw M; Dinan TG; Cryan JF; Schellekens H FASEB J; 2019 Jan; 33(1):518-531. PubMed ID: 30020830 [TBL] [Abstract][Full Text] [Related]
10. A relationship between motilin and growth hormone secretagogue receptors. Nunoi H; Matsuura B; Utsunomiya S; Ueda T; Miyake T; Furukawa S; Kumagi T; Ikeda Y; Abe M; Hiasa Y; Onji M Regul Pept; 2012 Jun; 176(1-3):28-35. PubMed ID: 22465164 [TBL] [Abstract][Full Text] [Related]
11. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway. Mousseaux D; Le Gallic L; Ryan J; Oiry C; Gagne D; Fehrentz JA; Galleyrand JC; Martinez J Br J Pharmacol; 2006 Jun; 148(3):350-65. PubMed ID: 16582936 [TBL] [Abstract][Full Text] [Related]
12. The β-cell GHSR and downstream cAMP/TRPM2 signaling account for insulinostatic and glycemic effects of ghrelin. Kurashina T; Dezaki K; Yoshida M; Sukma Rita R; Ito K; Taguchi M; Miura R; Tominaga M; Ishibashi S; Kakei M; Yada T Sci Rep; 2015 Sep; 5():14041. PubMed ID: 26370322 [TBL] [Abstract][Full Text] [Related]
13. The ups and downs of growth hormone secretagogue receptor signaling. Cornejo MP; Mustafá ER; Cassano D; Banères JL; Raingo J; Perello M FEBS J; 2021 Dec; 288(24):7213-7229. PubMed ID: 33460513 [TBL] [Abstract][Full Text] [Related]
14. Design and characterization of a triazole-based growth hormone secretagogue receptor modulator inhibiting the glucoregulatory and feeding actions of ghrelin. Péraldi-Roux S; Bayle M; M'Kadmi C; Damian M; Vaillé J; Fernandez G; Cornejo MP; Marie J; Banères JL; Ben Haj Salah K; Fehrentz JA; Cantel S; Perello M; Denoyelle S; Oiry C; Neasta J Biochem Pharmacol; 2022 Aug; 202():115114. PubMed ID: 35659880 [TBL] [Abstract][Full Text] [Related]
15. Ghrelin mRNA and GH secretagogue receptor mRNA in human GH-producing pituitary adenomas is affected by mutations in the alpha subunit of G protein. Kim K; Sanno N; Arai K; Takano K; Yasufuku-Takano J; Teramoto A; Shibasaki T Clin Endocrinol (Oxf); 2003 Nov; 59(5):630-6. PubMed ID: 14616888 [TBL] [Abstract][Full Text] [Related]
16. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Kojima M; Hosoda H; Kangawa K Horm Res; 2001; 56 Suppl 1():93-7. PubMed ID: 11786694 [TBL] [Abstract][Full Text] [Related]
17. Agonist-specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine. Carreira MC; Camiña JP; Smith RG; Casanueva FF Neuroendocrinology; 2004 Jan; 79(1):13-25. PubMed ID: 14755130 [TBL] [Abstract][Full Text] [Related]
18. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Yin Y; Li Y; Zhang W Int J Mol Sci; 2014 Mar; 15(3):4837-55. PubMed ID: 24651458 [TBL] [Abstract][Full Text] [Related]
20. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR). Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]